The emerging role of nanotechnology in pursuit of successful drug delivery to H3K27M diffuse midline gliomas

Erica A Power^{1

2}, Julian S Rechberger^{1

2}, Victor M Lu³, David J Daniels^{1

4}

Affiliations

¹ Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
² Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
³ Department of Neurologic Surgery, University of Miami, Miami, FL 33136, USA.
⁴ Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.

Editorial

Erica A Power et al. Nanomedicine (Lond). 2021 Jul.

. 2021 Jul;16(16):1343-1346.

doi: 10.2217/nnm-2021-0067. Epub 2021 May 17.

Erica A Power^{1

2}, Julian S Rechberger^{1

2}, Victor M Lu³, David J Daniels^{1

4}

¹ Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
² Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
³ Department of Neurologic Surgery, University of Miami, Miami, FL 33136, USA.
⁴ Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.

No abstract available

Keywords: blood–brain barrier; convection-enhanced delivery; diffuse midline glioma; nanoparticle.

Publication types